Tenon Medical, Inc. Common Stock
TNONStock
$0.20−80.22%52W
Market Cap$3.44M
P/E—
Div yield—
Beta1.43
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-89.48%
Price vs S&P 500 (4W)-67.15%
VGM Score61.73
Market Capitalization$3.44M
Earnings Surprise History
Q1 26-0.31est. -0.31
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.13
4.13
4.13
4.13
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TNONTenon Medical, Inc. Common Stock | A | A | F | $0.20 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Tenon Medical develops minimally invasive solutions for treating sacroiliac joint disorders, a significant source of lower back pain. The company's Catamaran System—a single titanium implant—serves three market opportunities: primary procedures, revision surgeries, and spine fusion adjuncts. Currently, revenue is generated through sales to a limited number of clinicians, with potential for expansion as clinical adoption grows.